Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W5QJ
|
|||
| Former ID |
DIB013889
|
|||
| Drug Name |
Anti-HIV ribozyme therapy
|
|||
| Synonyms |
OZ1; RRZ2; HIV ribozyme gene therapy, Gene Shears; Gene therapy (HIV), Gene Shears; Anti-HIV ribozyme therapy, Johnson & Johnson; Anti-HIV-1 gene transfer product, Johnson & Johnson
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1/2 | [1] | |
| Company |
Gene Shears Pty Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Tat protein (HIV tat) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt. Stem Cells Int. 2011;2011:393698. | |||
| REF 2 | Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS. Methods Mol Biol. 2004;252:581-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.